NCT00098995View on ClinicalTrials.gov

Tirapazamine, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Cervical Cancer
Interventions
DRUG

cisplatin

DRUG

tirapazamine

RADIATION

brachytherapy

RADIATION

radiation therapy

Trial Locations (2)

8006

Peter MacCallum Cancer Centre, East Melbourne

M5G 2M9

Princess Margaret Hospital, Toronto

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Peter MacCallum Cancer Centre, Australia

OTHER

NCT00098995 - Tirapazamine, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer | Biotech Hunter | Biotech Hunter